Literature DB >> 12370476

Heterogeneity of presenile dementia with bone cysts (Nasu-Hakola disease): three genetic forms.

T Kondo1, K Takahashi, N Kohara, Y Takahashi, S Hayashi, H Takahashi, H Matsuo, M Yamazaki, K Inoue, K Miyamoto, T Yamamura.   

Abstract

Nasu-Hakola disease (NHD) is an autosomal recessive disorder characterized by presenile dementia and bone cysts. Finnish patients revealed a large deletion in DAP12 gene encoding a key element for transducing activation signal. The authors examined six Japanese cases for DAP12 alleles. Five of the six had loss-of-function mutation, either a single-base deletion or a novel point mutation. The single patient without mutation normally expressed DAP12 protein. Japanese NHD has at least three genetic forms regarding DAP12.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370476     DOI: 10.1212/wnl.59.7.1105

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

Review 1.  DAP12 signaling: from immune cells to bone modeling and brain myelination.

Authors:  Marco Colonna
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

Review 2.  Nothing but skin and bone.

Authors:  F Patrick Ross; Angela M Christiano
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

3.  Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.

Authors:  Atsushi Sasaki; Akiyoshi Kakita; Kunihiro Yoshida; Takuya Konno; Takeshi Ikeuchi; Shintaro Hayashi; Hidenori Matsuo; Kei Shioda
Journal:  Neurogenetics       Date:  2015-05-23       Impact factor: 2.660

Review 4.  Microglia and inflammation: conspiracy, controversy or control?

Authors:  Adelaide Fernandes; Leonor Miller-Fleming; Teresa F Pais
Journal:  Cell Mol Life Sci       Date:  2014-07-10       Impact factor: 9.261

5.  Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease.

Authors:  L M Bekris; M Khrestian; E Dyne; Y Shao; J A Pillai; S M Rao; S M Bemiller; B Lamb; H H Fernandez; J B Leverenz
Journal:  J Neuroimmunol       Date:  2018-03-20       Impact factor: 3.478

6.  A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells.

Authors:  Megan M Varnum; Kevin A Clayton; Asuka Yoshii-Kitahara; Grant Yonemoto; Lacin Koro; Seiko Ikezu; Tsuneya Ikezu
Journal:  J Biol Chem       Date:  2017-05-10       Impact factor: 5.157

7.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2).

Authors:  Yuka Atagi; Chia-Chen Liu; Meghan M Painter; Xiao-Fen Chen; Christophe Verbeeck; Honghua Zheng; Xia Li; Rosa Rademakers; Silvia S Kang; Huaxi Xu; Steven Younkin; Pritam Das; John D Fryer; Guojun Bu
Journal:  J Biol Chem       Date:  2015-09-15       Impact factor: 5.157

8.  Targeted sequencing approach to identify genetic mutations in Nasu-Hakola disease.

Authors:  Jun-Ichi Satoh; Motoaki Yanaizu; Youhei Tosaki; Kenji Sakai; Yoshihiro Kino
Journal:  Intractable Rare Dis Res       Date:  2016-11

9.  OSCAR is a collagen receptor that costimulates osteoclastogenesis in DAP12-deficient humans and mice.

Authors:  Alexander David Barrow; Nicolas Raynal; Thomas Levin Andersen; David A Slatter; Dominique Bihan; Nicholas Pugh; Marina Cella; Taesoo Kim; Jaerang Rho; Takako Negishi-Koga; Jean-Marie Delaisse; Hiroshi Takayanagi; Joseph Lorenzo; Marco Colonna; Richard W Farndale; Yongwon Choi; John Trowsdale
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

Review 10.  Osteoclast motility: putting the brakes on bone resorption.

Authors:  Deborah V Novack; Roberta Faccio
Journal:  Ageing Res Rev       Date:  2009-09-27       Impact factor: 10.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.